Media: Lack of buyers' interest in Novo Holdings-owned Xellia Pharmaceuticals
Equity firms haven’t shown any noteworthy interest in buying Danish Xellia Pharmaceuticals, which is owned by Novo Holdings.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
Novo Holdings’ hopes of selling antibiotics producer Xellia Pharmaceuticals have run aground, Danish business daily Børsen has learned.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Holdings appoints new CFO
For subscribers
